CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-30 | Connaughton Bernadette Director | Grant or award | +8,829 | 26,783 | ||
| 2020-04-30 | BIZZARI JEAN-PIERRE Director | Grant or award | +8,829 | 82,314 | ||
| 2020-04-01 | Sun Elaine D SVP, Chief Financial Officer | Grant or award · Performance Stock Units | +40,796 | 40,796 | ||
| 2020-03-19 | Kelley Kenneth J Director | Purchase | +17,543 | $14.19 | $249K | 242,467 |
| 2020-03-19 | Kelley Kenneth J Director | Purchase | +17,543 | $14.25 | $250K | 260,010 |
| 2020-03-19 | Kelley Kenneth J Director | Purchase | +17,543 | $14.24 | $250K | 277,553 |
| 2020-03-02 | Sun Elaine D SVP, Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +104,969 | 104,969 | ||
| 2020-03-02 | Sun Elaine D SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +48,662 | 48,662 | ||
| 2020-02-22 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +8,803 | 179,231 | ||
| 2020-02-22 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −3,044 | $21.83 | $66K | 176,187 |
| 2020-02-22 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −8,803 | 8,803 | ||
| 2020-02-22 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion | +11,392 | 120,675 | ||
| 2020-02-22 | Stelzer Laurie SVP, Chief Financial Officer | Shares withheld for taxes | −4,508 | $21.83 | $98K | 116,167 |
| 2020-02-22 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −11,392 | 11,392 | ||
| 2020-02-22 | Torley Helen President and CEO | Exercise or conversion | +39,354 | 510,033 | ||
| 2020-02-22 | Torley Helen President and CEO | Shares withheld for taxes | −19,511 | $21.83 | $426K | 490,522 |
| 2020-02-22 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −39,354 | 39,354 | ||
| 2020-02-14 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +5,772 | 172,423 | ||
| 2020-02-14 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −1,995 | $21.10 | $42K | 170,428 |
| 2020-02-14 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −5,772 | 11,542 |
Page 56 of 59 · 1,177 trades